ADVA
6.10.2020 09:02:14 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced the general availability of its Ensemble Activator , the market’s first carrier-grade network operating system (NOS) designed for disaggregated cell site gateways (DCSGs). Already successful in trials with multiple global mobile network operators (MNOs) including Telefónica and Vodafone, Ensemble Activator disaggregates hardware from software, giving customers new levels of agility and freedom. Developed as part of the Telecom Infra Project (TIP), the feature-rich software enables MNOs to move away from closed proprietary systems and build open, vendor-neutral transport infrastructure with best-of-breed components. Now ready for commercial deployment in mobile networks, it offers MNOs a clear route to cost-effective mass rollout of 5G services.
“Today’s announcement marks the start of a new age of disaggregated mobile networks. By deploying our Ensemble Activator, MNOs will be able to leverage the full benefits of separated software and hardware and inject unprecedented speed, efficiency and flexibility into their transport infrastructure,” said Eli Angel, VP, product line management, Ethernet access, ADVA. “Built on our team’s vast experience equipping the largest public networks with the most advanced connectivity solutions, Ensemble Activator has now proven itself in a wide range of real-life scenarios. These include 5G field trials where Ensemble Activator combined with third-party white box hardware to create an open and cohesive DCSG solution . By turning cost-effective bare-metal switches into powerful packet network devices, it will equip MNOs to build tomorrow’s mobile infrastructure.”
Engineered through the TIP Disaggregated Cell Site Gateway group, ADVA’s Ensemble Activator is optimized for the operation of large, geographically dispersed networks. Proven in multiple tests with third-party hardware from suppliers such as Alpha Networks, Delta and Edgecore, it integrates seamlessly into existing management and control systems. With its carrier-class capabilities, Ensemble Activator offers a way to grow mobile networks that combines the agility of software-based feature development with the performance and cost-efficiency of bare-metal switches. Its comprehensive set of CE 2.0- and MEF 3.0-compliant interfaces is complemented with proven IP and MPLS protocols. What’s more, with its open control interfaces and telemetry streaming, Ensemble Activator is a significant step towards automated and eventually autonomous operations.
“Supporting the disaggregation of hardware and software while meeting the performance needs of the most demanding mobile networks is critical in transitioning today’s technology to open, highly scalable mobile transport architectures and enabling the mass rollout of 5G services. We are very excited about ADVA’s Ensemble Activator, as it offers something new to the market and enables a strong ecosystem for DCSG technology,” commented Luis MartinGarcia, manager, network technologies, Facebook and co-chair, DCSG group, TIP. “TIP is all about unleashing the power of collaboration and open innovation, and ADVA’s work demonstrates how quickly we build together in TIP to bring a powerful new technology to maturity.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005045/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom